علاج الالتهاب الرئوي الحاد بالحمضات مع الفشل التنفسي

References

The attending physician chose a regimen based on the presence of respiratory failure defined as a Pa,O2/FI,O2 ratio ≤300 and/or tachypnea (respiration rate >30 breaths·min⁻¹).

When the patient had respiratory failure, methylprednisolone was administered intravenously for 3 days and then changed to oral prednisolone twice a day (fig. 1).

All symptoms improved after a median of 7 (4–10) days; defervescence occurred within 48 h in all patients and dyspnoea was improved within 3 (2–5) days.

The majority of pulmonary infiltrates on chest radiographs disappeared within 7 days after corticosteroid treatment, which is consistent with previous reports.